Verizon Communications Inc. (VZ) Rallies 8.84% After Earnings
· Stocks · QuoteReporter
Post Earning Analysis
Verizon Communications Inc. (VZ) Rallies 8.84% After Earnings
Verizon Communications, Inc. is a leading global provider of communications, information, and entertainment products and services. Founded in 1983 and headquartered in New York, NY, Verizon operates through two main segments: Consumer and Business. The Consumer segment focuses on wireless and wireline communications for individual customers, while the Business segment caters to corporate needs with a broad range of services including broadband, data, and network solutions.
Verizon has recently reported a strong performance in its Q4 earnings, surpassing estimates on both earnings and revenue fronts, which has contributed to a sharp rise in its stock price. The company achieved its best subscriber growth since 2019, with significant gains under the leadership of its new CEO. Additionally, Verizon provided an upbeat profit outlook for 2026 and announced a substantial $25 billion buyback program. This series of positive reports reflects a robust operational stance and has likely bolstered investor confidence in Verizon’s stock. The company’s strategic moves and solid financial guidance under new leadership are expected to keep the stock in a favorable position in the near term. This performance is particularly notable amid a broader market environment where other major stocks and indices have shown mixed results, influenced by factors like the appointment of Kevin Warsh as Trump’s Fed pick and various big tech earnings.
The current price of the asset is $43.39, showing a significant increase of 8.84% today. This price is near its 52-week and year-to-date highs of $44.33, indicating a strong upward momentum, as it is only approximately 2.12% below these peaks. The price is substantially higher than both the 52-week low of $36.64 and the year-to-date low of $35.18, with increases of 18.42% and 23.34% respectively, highlighting a robust recovery over the past year.
The asset has also shown strong performance over the past week, with today’s price only 0.28% below the week high of $43.51 and 10.72% above the week low of $39.19. The moving averages suggest a bullish trend, with the current price exceeding the 20-day, 50-day, and 200-day moving averages by 9.31%, 8.84%, and 6.46% respectively.
The technical indicators further support the bullish outlook. An RSI of 76.64 indicates that the asset might be considered overbought, which could suggest a potential pullback or consolidation in the near term. However, the MACD of 0.25 points to ongoing positive momentum. This combination of price performance and technical indicators suggests that while the asset is currently strong, investors should be cautious of potential volatility or corrective movements due to the high RSI level.
Earnings Trend Table
| Earnings Date | Date | Estimate EPS | Reported EPS | Surprise % |
|---|---|---|---|---|
| 2025-04-22 06:54:00-04:00 | 2025-04-22 | 1.15 | 1.19 | 3.69 |
| 2025-01-24 06:55:00-05:00 | 2025-01-24 | 1.10 | 1.10 | 0.46 |
| 2024-10-22 07:00:00-04:00 | 2024-10-22 | 1.18 | 1.19 | 1.17 |
| 2024-07-22 07:00:00-04:00 | 2024-07-22 | 1.15 | 1.15 | 0.26 |
| 2024-04-22 07:00:00-04:00 | 2024-04-22 | 1.12 | 1.15 | 2.73 |
| 2024-01-23 07:00:00-05:00 | 2024-01-23 | 1.07 | 1.08 | 0.56 |
| 2023-10-24 07:00:00-04:00 | 2023-10-24 | 1.18 | 1.22 | 3.54 |
| 2023-07-25 07:00:00-04:00 | 2023-07-25 | 1.17 | 1.21 | 3.86 |
The provided earnings data reveals a generally positive trend in the reported earnings per share (EPS) over the observed quarters. Starting from Q3 2023, the company has consistently met or exceeded EPS estimates, with reported EPS figures showing a gradual increase over time.
In Q3 2023, the reported EPS was $1.21, surpassing the estimate of $1.17 by 3.86%. This trend of outperforming EPS estimates continued, with Q4 2023 reporting an EPS of $1.22 against an estimate of $1.18, marking a 3.54% surprise. The following year, 2024, showed a mix of exact matches and slight surpasses against estimates. For instance, Q1 and Q3 2024 reported EPS exactly as predicted or with minimal surprises, whereas Q2 and Q4 of the same year saw EPS outperform estimates by modest margins of 2.73% and 1.17%, respectively.
The trend persisted into 2025, with Q1 2025 reporting an EPS exactly in line with estimates, and Q2 2025 exceeding expectations by 3.69%. This pattern suggests not only effective earnings management but also a consistent ability to meet or slightly exceed analyst expectations, which could be indicative of stable financial planning and execution by the company. The overall upward trajectory in EPS across the quarters, coupled with generally positive surprise percentages, points to robust financial health and operational efficiency.
Dividend Payments Table
| Date | Dividend |
|---|---|
| 2026-01-12 | 0.69 |
| 2025-10-10 | 0.69 |
| 2025-07-10 | 0.678 |
| 2025-04-10 | 0.678 |
| 2025-01-10 | 0.678 |
| 2024-10-10 | 0.678 |
| 2024-07-10 | 0.665 |
| 2024-04-09 | 0.665 |
The dividend data over the observed periods from April 2024 to January 2026 shows a pattern of gradual increase. Initially, dividends were maintained at $0.665 per share for two consecutive quarters in 2024 (April and July). A slight uptick was observed starting from October 2024, where dividends increased to $0.678 per share and remained consistent at this rate through the subsequent three quarters until July 2025.
A notable change occurred in October 2025, when dividends rose to $0.69 per share, marking the highest payout in the observed data set. This increase was sustained in the most recent data point from January 2026, indicating a potential stabilization at this higher rate.
The trend suggests a cautious yet positive approach to dividend growth, reflecting possibly an improved financial outlook or a strategy to return more value to shareholders. Such incremental increases are often indicative of a company’s confidence in its sustained earnings and cash flow, ensuring that it can support higher payouts without compromising financial stability.
The recent rating changes for the company in question reflect varied perspectives from different financial institutions, with actions taken over a span of approximately six months.
-
Barclays – January 22, 2026: Barclays resumed coverage on the company with an “Equal Weight” rating, setting a target price at $43. This rating suggests that Barclays views the company’s stock as adequately valued at its current price, not presenting significant overperformance or underperformance relative to the broader market or sector.
-
BNP Paribas Exane – October 21, 2025: BNP Paribas Exane downgraded the company from “Outperform” to “Neutral” with a slightly higher target price of $44. This downgrade indicates a shift in expectation, where BNP Paribas Exane no longer foresees the company outperforming the market, though the target price adjustment suggests a marginal improvement in the stock’s valuation perspective.
-
Goldman Sachs – September 2, 2025: Goldman Sachs resumed coverage with a “Buy” rating and set a target price of $49, the highest among the recent ratings. This optimistic outlook implies that Goldman Sachs expects the company to perform well and deliver returns above the market average, highlighting potential growth or recovery not recognized by others.
-
Morgan Stanley – July 10, 2025: Morgan Stanley also resumed coverage by assigning an “Equal-Weight” rating with a target price of $47. Similar to Barclays, Morgan Stanley’s rating indicates a neutral perspective on the stock’s future performance relative to the market, suggesting that the stock is fairly valued at its current level.
Overall, these ratings show a mix of cautious optimism and neutrality towards the company’s stock, with financial institutions projecting target prices within a $6 range, reflecting differing expectations about the company’s market performance and underlying value.
The current price of the stock is $43.39. Analyst ratings from prominent financial institutions suggest a varied outlook on the stock’s future performance, with target prices ranging from $43 to $49. The average target price from these ratings is approximately $45.75, indicating a modest potential upside from the current market price.
The ratings include an ‘Equal Weight’ from Barclays with a target of $43, a downgrade from ‘Outperform’ to ‘Neutral’ by BNP Paribas Exane with a target of $44, a ‘Buy’ rating from Goldman with a target of $49, and an ‘Equal-Weight’ from Morgan Stanley with a target of $47. These assessments suggest a cautious optimism, with a lean towards maintaining a balanced position in portfolio allocations.
While specific EPS (Earnings Per Share) and dividend trends are not detailed in the provided data, the range of target prices and the mix of ratings imply a stable yet cautiously optimistic outlook on the stock’s earnings potential and dividend reliability moving forward.
Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.